Introduction
Medical device registration in the European Union is the structured regulatory and operational function through which a manufacturer determines whether a device may be lawfully placed on the Union market under Regulation (EU) 2017/745 for medical devices or Regulation (EU) 2017/746 for in vitro diagnostic medical devices, completes the relevant conformity pathway and establishes the registration, documentation, traceability and post-market controls required for continuing market access.
In practical terms, the EU model is not a simple one-office filing system. The route depends on device type, intended purpose, risk class, economic operator configuration, whether notified body involvement is required and whether the product falls under MDR or IVDR rather than under another product regime.
The subject is commercially important because a compliant EU registration strategy can support access across the internal market, while defects in classification, conformity assessment, technical documentation, UDI, registration records or vigilance preparation can disrupt cross-border distribution and expose the business to enforcement by competent authorities in one or more Member States.
Home
└── Jurisdictions
└── European Union
└── Medical Device Registration European Union
Identity
- Object: Medical Device Registration
- Jurisdiction: European Union
- Object ID: EU.MDR.001
- Reference: MAR-EU-MDR-001-A
Core Framework
- MDR for medical devices
- IVDR for in vitro diagnostics
- Notified body system where third-party assessment is required
- EUDAMED, UDI and post-market vigilance architecture
Operating Logic
- Classification-led, not form-led
- Documentation and evidence intensive
- Union-level rules with Member State enforcement
- Cross-border market access relevance is high
Executive Summary
Medical device registration in the European Union is the practical process through which a business determines which Union medical-device framework applies, classifies the device correctly, identifies whether the conformity assessment route is self-managed or requires a notified body, and prepares the documentation, registration data and post-market systems needed before lawful market placement.
The function does not begin with uploading data to a portal. It begins with device qualification, intended purpose analysis, rule-based classification, regulatory strategy, economic operator mapping and evidence planning. Registration in the EU is therefore inseparable from conformity assessment and lifecycle compliance.
The legal architecture is built primarily around MDR and IVDR. MDR governs medical devices generally, while IVDR governs in vitro diagnostic medical devices. Guidance from the Medical Device Coordination Group assists in applying those regulations, and the Commission publishes designated notified bodies through the NANDO information system where third-party conformity assessment is required.
Cross-border relevance is central because EU conformity and registration logic is designed to support market access across Member States within the internal market. At the same time, supervision remains operationally linked to competent authorities and enforcement bodies at national level, which means a manufacturer must think in one Union framework and many possible national enforcement contexts.
| Definition | The professional regulatory and market-access function concerned with establishing whether a device may lawfully enter and remain on the EU market under MDR or IVDR, including classification, conformity assessment, registration data, technical documentation, traceability and post-market obligations. |
| Object | Medical Device Registration |
| Object Type | Professional Regulatory and Market-Access Function |
| Classification | Medical Devices, IVDs, Regulatory Strategy, Conformity Assessment, UDI, EUDAMED, Post-Market Surveillance, Cross-Border Trade |
| Jurisdiction | European Union |
Definition
Medical device registration in the European Union refers to the structured legal and operational process by which a device is qualified as a medical device or IVD, placed within the correct EU regulatory framework, assessed through the correct conformity route, documented in the form required by the applicable regulation and made traceable through the relevant registration and identification mechanisms before market placement.
The subject is broader than database entry. It includes intended purpose analysis, classification, general safety and performance requirements, clinical or performance evidence, quality-system interfaces, labelling, UDI strategy, authorised representative questions where relevant, importer and distributor positioning, and readiness for vigilance and market surveillance after launch.
| Covered Matters | Device qualification, MDR/IVDR routing, risk classification, conformity assessment planning, notified body involvement where required, technical documentation, declaration work, CE marking, UDI, EUDAMED-related registration logic, economic operator mapping, vigilance preparation and post-market compliance support. |
| Functional Boundary | The Registry Object covers how businesses achieve and maintain lawful EU market access for medical devices and IVDs within the Union regulatory framework. |
| Related but Not Primary | Patent strategy, reimbursement design, hospital procurement tactics, pure commercial distribution negotiations and general healthcare marketing are adjacent but not the primary object here. |
| Outside Scope | Purely non-medical consumer products, unrelated pharmaceuticals regulation, general company incorporation and purely promotional claims strategy. |
Scope
The EU medical device registration function applies to medical devices and in vitro diagnostic medical devices intended for placement on the Union market. The exact obligations vary according to product qualification, intended purpose, risk class, sterility or measuring functions where relevant, software characteristics, clinical role and whether the product falls under MDR or IVDR.
The central scope question is not simply whether the product is regulated, but how it is regulated. A business must first establish whether the product is a medical device, an IVD, an accessory, software, a system or procedure pack component, or something outside the medical-device framework. Only then can the correct registration route be identified.
Editorial Note: In the European Union, medical device registration is inseparable from conformity assessment. A business cannot treat registration as a standalone filing exercise divorced from classification, technical documentation, quality controls and post-market obligations.
Purpose
The purpose of medical device registration in the European Union is to convert a device concept, technical file, evidence base and supply-chain model into a legally supportable market-access position under the applicable Union framework.
In practical business terms, the function exists to reduce market-entry uncertainty, support lawful CE-marked placement where applicable, create traceability and establish a defensible compliance record for customers, notified bodies, importers and enforcement authorities.
Primary Outcome
A coherent EU medical device registration position means that the device has been qualified correctly, matched to MDR or IVDR as applicable, classified properly, assessed through the correct conformity route, documented adequately, linked to the necessary operator and traceability architecture and prepared for lawful market entry and post-market control.
For many devices, the outcome includes a completed conformity assessment, CE marking readiness, an EU declaration of conformity, appropriate registration data and a practical operating model for vigilance, complaints, corrective actions and authority engagement.
Request Contexts
Request contexts show the business situations in which EU medical device registration work is usually activated. In most cases, the work begins before launch, but it may also be triggered by design changes, legacy-device transition planning, distribution changes or authority scrutiny.
| Identity Pattern | Manufacturer preparing first EU entry, non-EU manufacturer appointing an authorised representative, IVD developer moving into IVDR scope, software company assessing medical-device qualification, importer validating EU readiness, private-label actor mapping legal responsibilities. |
| Business Event | New device launch, classification uncertainty, notified body engagement, certificate transition work, EUDAMED preparation, distributor onboarding, post-market system buildout, corrective action response or cross-border EU expansion. |
| Typical User | Manufacturers, regulatory affairs managers, quality leaders, legal counsel, authorised representatives, importers, product development teams and international market-entry advisors. |
| Typical Scenario | A business needs to determine whether its product is an EU medical device or IVD, which classification rules apply, whether a notified body is needed, what technical documentation and declarations must be completed and how the device should be positioned for lawful cross-border market placement. |
Typical Users
Different actors encounter EU medical device registration from different operational positions. The common thread is that each needs a defensible answer to who carries the legal obligations, what conformity pathway applies and what evidence supports market placement.
| Manufacturer | Needs to qualify the device, establish classification, compile technical documentation, select the correct conformity route and maintain post-market compliance. |
| Authorised Representative | Needs clarity on mandate scope, manufacturer status, documentation availability and the practical interface with EU authorities where the manufacturer is outside the Union. |
| Importer | Needs confidence that the device entering the Union market satisfies documentation, marking and operator requirements before distribution begins. |
| Regulatory Affairs or Quality Lead | Needs to align regulatory strategy, QMS interfaces, evidence generation, notified body planning and lifecycle controls. |
| Legal or Transaction Advisor | Needs to understand how product qualification, economic-operator structure, certificate status and post-market obligations affect commercial risk. |
Typical Scenarios
Practical scenarios help illustrate the threshold questions that usually trigger EU registration work for medical devices.
| Initial Qualification Review | A business must determine whether the product is a medical device, an IVD, software within scope or a non-device product. |
| Classification Planning | The company needs to apply the classification rules correctly because risk class drives the conformity route and the likelihood of notified body involvement. |
| Notified Body Route Selection | The manufacturer must determine whether self-declaration is available or a designated notified body is required under MDR or IVDR. |
| Legacy Transition Review | An existing product portfolio needs to be assessed against transitional provisions and the practical requirements for moving into the MDR or IVDR framework. |
| EUDAMED and Traceability Preparation | The business is preparing UDI and registration processes and needs a coherent data and documentation model. |
| Post-Market or Authority Event | A vigilance issue, document request or enforcement concern requires confirmation that the registration and conformity position is supportable. |
Jurisdiction Characteristics
The European Union is not a single national registration office. It is a supranational regulatory framework with Union legislation, Commission-level coordination, guidance structures, notified body designation mechanisms and Member State competent-authority enforcement. That makes the jurisdiction highly system-oriented and documentation-intensive.
The business advantage is scale. A defensible EU registration and conformity strategy can support distribution across multiple Member States. The practical challenge is that enforcement, language expectations and operational interactions may still arise through national authorities and local market actors even though the governing rules are Union-wide.
| Operational Culture | Evidence-based, classification-driven and highly structured around technical documentation, conformity assessment and post-market lifecycle controls. |
| Legal Framework Orientation | Union regulation with harmonised core rules under MDR and IVDR, supplemented by guidance, notified body designation and Member State enforcement. |
| Commercial Context | Internal market access can make a single EU registration strategy commercially powerful, but only if it is built on correct qualification, classification and documentation. |
| Language Expectation | English is widely used in cross-border regulatory work, but labelling, instructions, declarations or authority-facing documentation may require Member State language adaptation depending on the market. |
Key Authorities
EU medical device registration combines Union-level rulemaking and support structures with national-level supervision. A manufacturer therefore operates within a networked architecture rather than a single licensing office.
| Official Name | European Commission |
| Official English Name | European Commission |
| Primary Role | Union-level authority responsible for the medical devices sector framework, implementation support and public information on MDR, IVDR and related systems. |
| Responsibilities | Publishes sector information, maintains medical-device regulatory pages, supports implementation of MDR and IVDR and oversees associated Union systems and policy coordination. |
| Typical Interaction | Usually indirect for most businesses, through legislation, official guidance, public notices and system architecture rather than through a routine individual registration filing office. |
| Official Website | European Commission medical devices sector |
| Cross-Border Relevance | Foundational to the Union-wide regulatory architecture. |
| Official Name | Medical Device Coordination Group |
| Official English Name | Medical Device Coordination Group (MDCG) |
| Primary Role | Guidance and coordination body supporting consistent application of MDR and IVDR. |
| Responsibilities | Issues endorsed guidance and interpretive materials to assist stakeholders in applying MDR and IVDR in practice. |
| Typical Interaction | Indirect but operationally important where manufacturers, advisors and notified bodies rely on MDCG guidance to interpret practical compliance questions. |
| Official Website | MDCG guidance |
| Cross-Border Relevance | High, because the guidance function supports consistent application across Member States. |
| Official Name | NANDO Information System |
| Official English Name | New Approach Notified and Designated Organisations (NANDO) |
| Primary Role | Public listing mechanism through which the Commission publishes designated notified bodies for relevant Union legislation. |
| Responsibilities | Allows businesses to identify designated notified bodies under MDR and IVDR where third-party conformity assessment is required. |
| Typical Interaction | Used when selecting or validating a notified body route for device certification planning. |
| Official Website | Notified bodies for medical devices |
| Cross-Border Relevance | High, because designation status and scope are relevant across the Union market. |
| Official Name | Competent Authorities of the Member States |
| Official English Name | National Competent Authorities |
| Primary Role | National supervisory and enforcement bodies for medical-device compliance within each Member State. |
| Responsibilities | May investigate compliance, request documentation, supervise vigilance and corrective actions and take enforcement steps in their jurisdiction. |
| Typical Interaction | Direct where a device is marketed, investigated, reported, challenged or subjected to post-market or vigilance review. |
| Official Website | Varies by Member State. |
| Cross-Border Relevance | High, because an issue arising in one Member State may affect the wider Union distribution strategy. |
Applicable Legislation
The applicable legislative framework depends first on whether the product is a medical device or an IVD and then on its classification and route to conformity. MDR and IVDR are the central instruments. Transitional provisions remain important for some legacy devices, but they operate subject to conditions and do not eliminate the need for an MDR- or IVDR-aligned strategy.
| Official Title | Regulation (EU) 2017/745 on medical devices |
| Year | 2017 |
| Purpose | Establishes the core Union legal framework for placing medical devices on the market and putting them into service, including conformity assessment, operator obligations, traceability and post-market requirements. |
| Typical Application | Used for medical devices other than IVDs, including software and accessories where the regulation applies. |
| Related Legislation | IVDR, implementing acts, MDCG guidance, notified body designation architecture and Union traceability systems. |
| Official Source | EUR-Lex MDR |
| Current Status | In force. |
| Official Title | Regulation (EU) 2017/746 on in vitro diagnostic medical devices |
| Year | 2017 |
| Purpose | Establishes the Union framework for IVD market access, conformity assessment, classification, evidence requirements and post-market obligations. |
| Typical Application | Used for in vitro diagnostic medical devices and related accessories within IVDR scope. |
| Related Legislation | MDR, implementing acts, MDCG guidance, transitional provisions and notified body architecture for IVDs. |
| Official Source | EUR-Lex IVDR |
| Current Status | In force. |
| Official Title | Transitional provisions for MDR and IVDR implementation |
| Year | Ongoing amendments |
| Purpose | Provide conditional transition windows for certain legacy devices while manufacturers move to the current regulatory framework. |
| Typical Application | Relevant where a business is managing portfolio transfer, certificate validity, notified body engagement or phased migration into the MDR or IVDR framework. |
| Related Legislation | MDR, IVDR and Commission implementation materials. |
| Official Source | European Commission transitional provisions |
| Current Status | Active and condition-based. |
Process Flow
EU medical device registration usually works as a staged process from product qualification to lifecycle maintenance. The sequence is strategic rather than clerical: an error at classification or conformity-route stage will normally undermine the later registration position.
| 1. Device Qualification | Define intended purpose, product functionality, user setting and determine whether the product falls within the medical-device or IVD framework. |
| 2. Legal Mapping | Determine whether MDR or IVDR applies, whether the product is a device, accessory or software and which legal obligations are triggered. |
| 3. Classification | Apply the applicable classification rules because risk class drives conformity assessment intensity and notified body requirements. |
| 4. Operator Allocation | Confirm who acts as manufacturer, authorised representative, importer and distributor in the Union supply structure. |
| 5. Conformity Route Selection | Establish whether self-declaration is available or whether a designated notified body must assess the device. |
| 6. Evidence and Documentation | Compile technical documentation, performance or clinical support, labelling set, declarations and quality-linked evidence. |
| 7. Traceability and Registration Setup | Prepare UDI and registration-related data architecture and ensure the relevant registration logic is operationally supportable. |
| 8. Market Placement | Place the device on the EU market only once the legal, documentary and operator structure is complete. |
| 9. Post-Market Maintenance | Maintain surveillance, vigilance, corrective-action readiness, change control and document retention through the product lifecycle. |
| Typical Outputs | Qualification memo, classification rationale, conformity strategy, technical documentation set, declaration materials, notified body pathway where required, operator map, traceability architecture and post-market governance file. |
Decision Tree
The threshold questions below simplify how the EU registration path is usually determined in practice.
- Identify what the product actually is, what medical purpose is claimed and whether the claim brings it within MDR or IVDR scope.
- Determine whether the product is a medical device, an IVD, an accessory, software or outside the framework.
- Apply the relevant classification rules and confirm the resulting risk class.
- Decide whether the conformity route allows self-declaration or requires a designated notified body.
- Map the economic operators, including authorised representative requirements where the manufacturer is outside the Union.
- Compile technical documentation, evidence, labelling, declaration and traceability materials.
- Confirm CE-marking readiness and the practical registration architecture before placement on the market.
- Prepare vigilance, surveillance response and lifecycle change-control systems.
Timeline
The EU registration timeline begins well before commercial launch and continues after placement on the market. For some portfolios, transitional provisions may create an additional layer of timing analysis, especially where legacy devices are migrating into the MDR or IVDR framework.
| Concept Stage | The business defines product purpose, technology, user setting and intended medical role. |
| Qualification Stage | The product is assessed to determine whether MDR or IVDR applies and whether the device falls within scope. |
| Classification Stage | Risk class is determined and the conformity route is mapped. |
| Assessment Stage | Technical evidence, quality-system interfaces and notified body planning are developed as required. |
| Registration Readiness Stage | Traceability, operator structure, declarations, labelling and registration-related data are prepared. |
| Launch Stage | The device is placed on the market only when the legal and documentary requirements are complete. |
| Monitoring Stage | The manufacturer maintains post-market surveillance, vigilance readiness, complaint handling and change control. |
| Transition Review Stage | Legacy portfolios may require additional planning around transitional provisions, certificate timing and migration milestones. |
Required Documents
The exact documents depend on device type and route, but EU medical device registration is highly document-dependent. Weak or incomplete documentation is often the main practical reason why market-entry projects stall or become hard to defend under scrutiny.
| Document | Qualification and Classification Record |
| Purpose | Explains why the product falls within MDR or IVDR scope and which class and conformity route apply. |
| Typical Situation | Prepared at the beginning of regulatory strategy work and revisited when scope or design assumptions change. |
| Document | Technical Documentation File |
| Purpose | Provides the structured evidence base supporting safety, performance, conformity and lifecycle control. |
| Typical Situation | Core file for conformity assessment, CE marking, audits, notified body review where applicable and authority response. |
| Document | EU Declaration of Conformity |
| Purpose | Formal manufacturer statement that the device complies with the applicable Union legislation. |
| Typical Situation | Used as part of lawful market placement once the conformity route has been completed. |
| Document | Notified Body Documentation |
| Purpose | Records third-party conformity assessment, certification or related review where the route requires notified body involvement. |
| Typical Situation | Relevant for device classes and procedures under MDR or IVDR that do not allow pure self-declaration. |
| Document | UDI and Registration Data Set |
| Purpose | Supports traceability and the operational registration architecture associated with EU medical-device systems. |
| Typical Situation | Used when setting up product identification, operator traceability and relevant registration records. |
| Document | Post-Market Surveillance and Vigilance Records |
| Purpose | Supports lifecycle compliance after market placement, including complaints, incidents, trends and corrective actions. |
| Typical Situation | Necessary throughout commercial operation and particularly important during inspections or safety events. |
Cross-Border Relevance
Cross-border relevance is exceptionally strong in the European Union because the medical-device framework is designed around Union-wide market access rather than around thirty separate primary registration systems. A sound registration strategy can therefore support distribution across multiple Member States within one legal architecture.
That said, operational reality remains multi-layered. Language requirements, local authority practice, importer arrangements, vigilance interactions and enforcement intensity may differ by market even where the underlying MDR or IVDR logic is common.
| Recognition | EU medical-device conformity and registration logic is intended to support internal-market circulation once the applicable requirements are met. |
| Foreign Companies | Non-EU manufacturers commonly need an EU-facing structure, especially around authorised representative appointment, importer mapping, documentation availability and practical authority access. |
| Language Considerations | Technical files may often be managed centrally, but labels, instructions and authority-facing materials may require adaptation for specific Member States. |
| International Rules | The EU framework interacts with global manufacturing and distribution models, but the market-access threshold is defined by MDR, IVDR and their implementation architecture. |
| Practical Considerations | Businesses should treat qualification, classification, conformity, operator mapping, traceability and post-market readiness as one integrated EU system rather than as disconnected filings. |
| Typical Risk | Assuming EU access is merely a CE-marking label exercise, overlooking authorised representative or importer structure, or underestimating the post-market obligations that continue after launch. |
MDRIVDREUDAMEDUDINotified BodiesInternal Market
Operating Constraints & Risks
Operating constraints identify the recurring failure points that affect EU medical device registration in practice. The most damaging mistakes often occur early, especially around qualification, classification and conformity-route selection.
| Qualification Risk | The product is misidentified as inside or outside the medical-device framework, causing the entire strategy to rest on a false premise. |
| Classification Risk | The risk class is mapped incorrectly, leading to the wrong conformity route or incorrect assumptions about notified body involvement. |
| Documentation Risk | The business cannot produce coherent technical documentation, declarations or supporting evidence when reviewed by a notified body, importer or authority. |
| Operator Allocation Risk | Manufacturer, authorised representative, importer and distributor roles are poorly structured or contractually unclear. |
| Traceability Risk | UDI and registration architecture is treated as an afterthought rather than as a core part of the compliance system. |
| Post-Market Risk | Complaint handling, vigilance and corrective-action systems are too weak to support the product after launch. |
| Transition Risk | The business misreads transitional provisions and assumes extra time is available without satisfying the required conditions. |
Costs & Fees
Costs in EU medical device registration usually do not arise from one universal central filing fee. They are driven by device complexity, classification, evidence generation, documentation depth, notified body involvement where required, operator structure and lifecycle compliance overhead.
| Assessment Costs | Device qualification, classification analysis, regulatory strategy, clinical or performance support and documentation work may create substantial advisory and internal resource costs. |
| Notified Body Costs | Arise where the conformity route requires third-party assessment, certification review or ongoing surveillance interfaces. |
| Documentation Costs | Technical file development, labelling review, declaration drafting, traceability setup and language adaptation can be material. |
| Operator Structure Costs | Authorised representative, importer coordination and contractual implementation may add recurring cost. |
| Maintenance Costs | Post-market surveillance, vigilance readiness, complaint handling, change control and document upkeep create continuing compliance expense. |
| Enforcement Costs | Corrective actions, recalls, remediation, retesting or authority response can significantly increase total cost exposure. |
FAQ
The FAQ section addresses threshold questions that commonly arise when businesses assess EU medical device registration.
| Is EU Medical Device Registration a Simple Central Filing? | No. It is a broader conformity and lifecycle function built around qualification, classification, documentation, operator structure and post-market obligations. |
| Does Every EU Medical Device Need a Notified Body? | No. Whether a notified body is required depends on the applicable regulation, the device type and the classification-driven conformity route. |
| Do MDR and IVDR Cover the Same Products? | No. MDR covers medical devices generally, while IVDR specifically governs in vitro diagnostic medical devices. |
| Is EUDAMED the Same Thing as Registration Itself? | No. EUDAMED is part of the regulatory architecture, but registration work begins much earlier with legal qualification, conformity planning and documentation readiness. |
| Can a Non-EU Manufacturer Access the EU Market Directly? | Often only with the correct EU-facing structure, including authorised representative and importer arrangements where applicable. |
| Do Obligations End Once the Device Is Launched? | No. Post-market surveillance, vigilance, change control and documentation maintenance remain integral after market placement. |
Practical Guidance
Practical guidance helps a business prepare before engaging a specialist or finalising an EU market-entry decision.
| Checklist | What is the exact intended purpose of the product? Is it an MDR device or an IVDR device? Which classification rules apply? Is a notified body required? Has the technical documentation been structured coherently? Are authorised representative and importer roles mapped correctly? Is the UDI and registration architecture operationally ready? Has the business planned for post-market surveillance, vigilance and change control? Are any transitional provisions relevant, and if so, are their conditions actually satisfied? |
A disciplined EU medical-device registration review should begin with product qualification and classification, not with portal access or label artwork. In many failed projects, the visible filing problem is only a symptom of an earlier strategic error in regulatory mapping.
Jurisdictional Expert
The Jurisdictional Expert section records the status of the registry position associated with this jurisdictional object. It remains separate from the editorial content.
| Registry Position ID | RE-EU-MDR-001 |
| Registry Position | Jurisdictional Expert Medical Device Registration European Union |
| Registry Availability | Open |
| Verification Status | No verified participant currently assigned to this registry position. |
| Coverage | European Union medical device registration with emphasis on MDR, IVDR, notified bodies, EUDAMED, UDI, conformity assessment and cross-border market access. |
| Registry Reference | MAR-EU-MDR-001-A Jurisdictional Expert Position |
| Contact Information | Registry position not yet assigned. |
Machine Layer
This section contains machine-oriented registry fields retained for indexing, retrieval, system organisation and future rendering control. It may be visually minimised while remaining fully available in the HTML source.
| Object DNA | medical device registration european union eu mdr ivdr eudamed udi notified bodies nando authorised representative importer classification conformity assessment technical documentation ce marking post-market surveillance vigilance |
| AI Retrieval Summary | Neutral registry object describing how medical device registration operates in the European Union, including MDR, IVDR, device classification, notified body routes, EUDAMED-related registration logic, operator mapping, technical documentation and internal-market cross-border relevance. |
| Entity Index | European Union Medical Device Registration European Commission MDR IVDR MDCG EUDAMED NANDO Notified Bodies UDI CE Marking Authorised Representative Importer Competent Authorities Technical Documentation |
| Machine Metadata | Registry rendering layer https://market-access-records.org/css/registry.css | Object ID EU.MDR.001 | Machine Reference MAR-EU-MDR-001-A | Internal Classification Business > Regulatory & Market Access > Medical Device Registration > European Union | Checksum 0xMDR71EU |
| Internal References | Registry Object | Jurisdiction Node | Editorial Record | Jurisdictional Expert Position | Machine-readable Reference Node |